This was considered to be a surrogate marker for the severity of pre transplant malnutrition. The rate of weight gain after transplant was not associated with post transplant diabetes. It should be noted that the mean BMI of this Indian cohort pre transplant was 18.3 ± 2.4 kg/m2. In this cohort malnutrition pre transplant was considered

to be the risk factor for post transplant diabetes. (Level II) There are no published studies examining the safety and efficacy of dietary interventions for the prevention and management of diabetes in adult kidney transplant recipients. Observational studies have indicated a correlation between pre-transplant weight and pre-transplant weight gain and the risk of developing type 2 diabetes after transplant suggesting that weight management for patients awaiting kidney transplant should be a priority. INCB018424 solubility dmso Kidney Disease Outcomes Quality Initiative: No recommendation. UK Renal Association: No recommendation. Canadian Society of Nephrology: No recommendation. European Best Practice Guidelines: Post-transplant diabetes mellitus should be treated as appropriate to achieve normoglycaemia.17 International Guidelines:

No recommendation. The suggestions for clinical care above are not in conflict with the European Best Practice Guidelines. No recommendations. Prospective, long-term controlled studies are required to examine the effectiveness of specific dietary modifications in the prevention and management of diabetes and impact of such modifications on the long-term health outcomes among kidney transplant recipients. Studies examining the effectiveness of intensive versus standard dietary interventions on the management

of selleck screening library diabetes – encompassing blood glucose, serum lipids and body weight – are also required. All of the selleck kinase inhibitor authors have no relevant financial affiliations that would cause a conflict of interest according to the conflict of interest statement set down by CARI. These guidelines were developed under a project funded by Greater Metropolitan Clinical Taskforce, New South Wales. “
“Aim:  To determine the precision of multi-frequency bioimpedance analysis (MFBIA) in quantifying acute changes in volume and nutritional status during haemodialysis, in patients with end-stage renal disease (ESRD). Methods:  Using whole-body MFBIA, we prospectively studied changes in total body water (TBW), extracellular volume (ECV), intracellular volume (ICV), lean body mass (LBM), body cell mass (BCM) and fat mass (FM), pre- and post-haemodialysis and tested the agreement of volume changes with corresponding acute weight change and ultrafiltration volume (UF) using Bland-Altman analysis. Results:  Forty-four prevalent and 17 incident haemodialysis patients were studied (median age 55 years, 56% males). MFBIA-derived TBW, ECV, ICV, LBM and BCM were significantly reduced after haemodialysis (P < 0.001), but FM remained constant. TBW change estimated weight change with mean bias of −0.